The effectiveness of dual antiviral treatment against COVID-19
This study evaluates the effectiveness of combination antiviral therapy for COVID-19 using Umifenovir and Oseltamivir compared with standard treatment. A total of 85 outpatients with confirmed COVID-19 were randomly assigned to two groups: 43 patients received combination antiviral therapy (Umifenovir 200 mg 4 times daily, Oseltamivir 75 mg twice daily for 7 days), and 42 received standard therapy based on WHO recommendations. The study spanned 16 months. Primary endpoints included the number of
Authors
- Mariia Ivanova (ORCID: https://orcid.org/0000-0002-7636-1000)
- А. І. Гоженко (ORCID: https://orcid.org/0000-0001-7413-4173)
- Д.Д. Іванов (ORCID: https://orcid.org/0000-0003-2609-0051)
Institutions
- Ukrainian Research Institute of Transport Medicine (UA)
- European Institute of Oncology (IT)
Publication Details
- Journal
- Journal Of Advanced Pharmacy Education And Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.51847/itovgoymnf
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00